Cargando…
Optimizing patient recruitment into clinical trials of antimicrobial-resistant pathogens
Recruitment of patients with critical priority antimicrobial-resistant (AMR) bacteria into drug approval randomized controlled trials (RCTs) has not been successful to date. Approaching from the viewpoint of clinician-investigators and learning from the experience of AMR-focused investigator-initiat...
Autores principales: | Paul, Mical, Dishon-Benattar, Yael, Dickstein, Yaakov, Yahav, Dafna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883721/ https://www.ncbi.nlm.nih.gov/pubmed/36726533 http://dx.doi.org/10.1093/jacamr/dlad005 |
Ejemplares similares
-
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii
por: Kon, Hadas, et al.
Publicado: (2023) -
Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
por: Paul, Mical, et al.
Publicado: (2015) -
Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol
por: Dickstein, Yaakov, et al.
Publicado: (2016) -
Duration of antibiotic treatment for Gram-negative bacteremia – Systematic review and individual participant data (IPD) meta-analysis
por: Turjeman, Adi, et al.
Publicado: (2022) -
Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity
por: Daitch, Vered, et al.
Publicado: (2021)